Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$834M |
| 2 |
FedEx
FDX
|
+$666M |
| 3 |
Microsoft
MSFT
|
+$594M |
| 4 |
Advanced Micro Devices
AMD
|
+$585M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.17B |
| 2 |
Amazon
AMZN
|
+$1.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 4 |
NVIDIA
NVDA
|
+$1.18B |
| 5 |
Wells Fargo
WFC
|
+$827M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.63% |
| 2 | Technology | 1.89% |
| 3 | Consumer Discretionary | 1.29% |
| 4 | Communication Services | 0.93% |
| 5 | Healthcare | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAN
3476
CALL
Canaan Creative
CAN
$283M
| $6.45M | ﹤0.01% |
1,055,500
-240,700
| -19% | -$1.87M |
|
3477
Ambarella
AMBA
$3.1B
| $6.44M | ﹤0.01% |
41,324
-1,788
| -4% | -$206K |
|
3478
PUT
Yelp
YELP
$1.26B
| $6.43M | ﹤0.01% |
172,800
-18,600
| -10% | -$705K |
|
3479
WEC Energy
WEC
$34.6B
| $6.42M | ﹤0.01% |
72,851
-15,212
| -17% | -$1.43M |
|
3480
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$358M
| $6.42M | ﹤0.01% |
59,500
-16,800
| -22% | -$1.85M |
|
|
SAGE
3481
DELISTED
Sage Therapeutics
SAGE
| $6.42M | ﹤0.01% |
144,972
+114,178
| +371% | +$5.24M |
|
3482
CALL
Vornado Realty Trust
VNO
$7.13B
| $6.41M | ﹤0.01% |
152,500
+32,700
| +27% | +$1.41M |
|
3483
CALL
Commercial Metals
CMC
$7.48B
| $6.41M | ﹤0.01% |
210,300
+43,700
| +26% | +$1.39M |
|
3484
PUT
Cognex
CGNX
$10.2B
| $6.4M | ﹤0.01% |
79,800
-28,500
| -26% | -$2.45M |
|
3485
Levi Strauss
LEVI
$8.19B
| $6.4M | ﹤0.01% |
261,175
+16,363
| +7% | +$441K |
|
3486
Robert Half
RHI
$4.64B
| $6.4M | ﹤0.01% |
63,759
+20,113
| +46% | +$1.97M |
|
|
DMTK
3487
CALL
DELISTED
DermTech, Inc. Common Stock
DMTK
| $6.4M | ﹤0.01% |
199,200
+92,800
| +87% | +$3.26M |
|
3488
Invesco
IVZ
$14.5B
| $6.39M | ﹤0.01% |
265,232
+41,912
| +19% | +$1.05M |
|
3489
PUT
Axsome Therapeutics
AXSM
$10.4B
| $6.38M | ﹤0.01% |
193,700
-7,300
| -4% | -$284K |
|
3490
PUT
iShares MSCI Hong Kong ETF
EWH
$1.26B
| $6.38M | ﹤0.01% |
266,100
-500
| -0.2% | -$12.9K |
|
3491
Motorola Solutions
MSI
$80.4B
| $6.38M | ﹤0.01% |
27,460
-20,680
| -43% | -$4.8M |
|
3492
Syndax Pharmaceuticals
SNDX
$1.74B
| $6.38M | ﹤0.01% |
333,806
+225,948
| +209% | +$3.77M |
|
3493
PUT
Genuine Parts
GPC
$19B
| $6.38M | ﹤0.01% |
52,600
+34,800
| +196% | +$4.34M |
|
|
VMRK
3494
CALL
Vivmark Residential
VMRK
$26.1B
| $6.37M | ﹤0.01% |
78,700
-18,000
| -19% | -$1.49M |
|
3495
CALL
JFrog
FROG
$12.2B
| $6.36M | ﹤0.01% |
189,900
-77,400
| -29% | -$3.11M |
|
3496
PUT
Revolve Group
RVLV
$1.63B
| $6.36M | ﹤0.01% |
103,000
-76,300
| -43% | -$4.97M |
|
3497
Schwab US Broad Market ETF
SCHB
$44.7B
| $6.36M | ﹤0.01% |
367,260
+229,764
| +167% | +$4.09M |
|
|
WEBR
3498
CALL
DELISTED
Weber Inc.
WEBR
| $6.35M | ﹤0.01% |
+361,000
| New | +$5.79M |
|
3499
CALL
Hyatt Hotels
H
$16.2B
| $6.34M | ﹤0.01% |
82,200
-16,600
| -17% | -$1.25M |
|
3500
PUT
Protagonist Therapeutics
PTGX
$9.34B
| $6.33M | ﹤0.01% |
357,500
+318,400
| +814% | +$13.6M |
|
Similar funds
Jeff Yass's Q3 2021 Portfolio in Review
As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
- Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
- Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
- Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
- Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
- Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
- Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.